A nationwide team of researchers report on interim results from a small, five-year study of transplantation of the individuals' own hematopoietic stem cells combined with high-dose immunotherapy in 24 people with relapsing-remitting MS. This procedure aims at "rebooting" the immune system to prevent MS immune attacks against the brain and spinal cord.
http://ift.tt/1xzFI0Q
http://ift.tt/1xzFI0Q
No comments:
Post a Comment